Kenneth Baillie

Chief Executive Officer

Professor Kenneth Baillie FRSE FMedSci is a computational biologist and critical care physician. As Professor of Translational Medicine at the University of Edinburgh and co-lead of the University’s Baillie-Gifford Pandemic Science Hub, he pioneers research that bridges genomics, biology, and clinical practice. Professor Baillie’s leadership of the world’s largest genome-wide association study (GWAS) on critical illness has yielded transformative insights, contributing to breakthroughs like the discovery of baricitinib as a COVID-19 treatment. His work exemplifies the power of collaborative science, with applications extending beyond medicine to fields such as agriculture, environmental science, and biotechnology. With over £100 million in career funding and publications in Nature, Science, NEJM, and The Lancet, Professor Baillie’s research has had major impact. As CEO of Multiscale, Professor Baillie will leverage his expertise in genomics, data science, and cross-species biological insights to drive our mission of creating an autonomously-learning computational model of life.